Search Results - "Begaud, B"

Refine Results
  1. 1

    Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study by Bruckert, Eric, Hayem, Gilles, Dejager, Sylvie, Yau, Caroline, Bégaud, Bernard

    Published in Cardiovascular drugs and therapy (01-12-2005)
    “…To characterize the risk factors, rate of occurrence, onset, nature and impact of mild to moderate muscular symptoms with high-dosage HMG-CoA reductase…”
    Get full text
    Journal Article
  2. 2

    Benzodiazepine use and risk of dementia: prospective population based study by Billioti de Gage, Sophie, Bégaud, Bernard, Bazin, Fabienne, Verdoux, Hélène, Dartigues, Jean-François, Pérès, Karine, Kurth, Tobias, Pariente, Antoine

    Published in BMJ (Online) (27-09-2012)
    “…Objective To evaluate the association between use of benzodiazepines and incident dementia.Design Prospective, population based study.Setting PAQUID study,…”
    Get full text
    Journal Article
  3. 3

    Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies by Verdoux, H., Tournier, M., Bégaud, B.

    Published in Acta psychiatrica Scandinavica (01-01-2010)
    “…Objective:  To review findings from pharmaco‐epidemiological studies exploring antipsychotic (AP) drugs prescribing trends. Method:  We retrieved original…”
    Get full text
    Journal Article
  4. 4

    When Patients Report Diseases That Prescribers Seem Unaware of: Discordance Between Patient and Physician Reporting of Risk-Related Previous History in NSAID Users From the CADEUS Study by Fourrier‐Réglat, A, Lacoin, L, Pariente, A, Lassalle, R, Robinson, P, Droz‐Perroteau, C, Bégaud, B, Blin, P, Moore, N D

    Published in Clinical pharmacology and therapeutics (01-11-2010)
    “…Prescribers are often unaware of possibly dangerous previous medical histories (PMHs) of their patients. Data from a study of nonsteroidal anti‐inflammatory…”
    Get full text
    Journal Article
  5. 5

    Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies by Verdoux, Helene, Lagnaoui, Rajaa, Begaud, Bernard

    Published in Psychological medicine (01-03-2005)
    “…A major public health issue is to determine whether long-term benzodiazepine use may induce cognitive deficits persisting after withdrawal. The aim of the…”
    Get more information
    Journal Article
  6. 6

    The Rennes Disaster: Lessons to be Drawn by Bégaud, B

    Published in Clinical therapeutics (01-08-2017)
    “…After a 3-month assessment period, the temporary specialized scientific committee (TSSC), set up by the Directorate of the French Medicines Agency (ANSM),…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Evaluation of statistical association measures for the automatic signal generation in pharmacovigilance by Roux, E., Thiessard, F., Fourrier, A., Begaud, B., Tubert-Bitter, P.

    “…Pharmacovigilance aims at detecting the adverse effects of marketed drugs. It is generally based on the spontaneous reporting of events thought to be the…”
    Get full text
    Journal Article
  9. 9

    Use of oral corticosteroids in the United Kingdom by van Staa, T.P., Leufkens, H.G.M., Abenhaim, L., Begaud, B., Zhang, B., Cooper, C.

    Published in QJM : An International Journal of Medicine (01-02-2000)
    “…Administration of oral corticosteroids is associated with the development of osteoporosis and an increased risk of fractures. However, the size of the treated…”
    Get full text
    Journal Article
  10. 10

    Rapid high-performance liquid chromatographic measurement of amisulpride in human plasma: application to manage acute intoxication by Péhourcq, F., Ouariki, S., Bégaud, B.

    Published in Journal of chromatography. B (05-06-2003)
    “…Amisulpride, a substituted benzamide derivative, is a second-generation (atypical) antipsychotic and is effective as maintenance therapy in patients with…”
    Get full text
    Journal Article Conference Proceeding
  11. 11

    Under-reporting of adverse drug reactions : Estimate based on a spontaneous reporting scheme and a sentinel system by ALVAREZ-REQUEJO, A, CARVAJAL, A, BEGAUD, B, MORIDE, Y, VEGA, T, ARIAS, L. H. M

    Published in European journal of clinical pharmacology (01-08-1998)
    “…Spontaneous reporting is the most common method used in pharmacovigilance and the best one to generate signals on new or rare adverse drug reactions (ADRs)…”
    Get full text
    Conference Proceeding Journal Article
  12. 12

    Adverse drug reactions in a department of systemic diseases-oriented internal medicine : prevalence, incidence, direct costs and avoidability by LAGNAOUI, R, MOORE, N, FACH, J, LONGY-BOURSIER, M, BEGAUD, B

    Published in European journal of clinical pharmacology (01-05-2000)
    “…Adverse drug reactions (ADRs) are a major cause of hospital admission and in-hospital morbidity. Departments of internal medicine are at the forefront of this…”
    Get full text
    Journal Article
  13. 13

    Impact of antidepressants on the risk of suicide in patients with depression in real-life conditions: a decision analysis model by Cougnard, A, Verdoux, H, Grolleau, A, Moride, Y, Begaud, B, Tournier, M

    Published in Psychological medicine (01-08-2009)
    “…The impact of antidepressant drug treatment (ADT) on the risk of suicide is uncertain. The aim of this study was to determine in a real-life setting whether…”
    Get more information
    Journal Article
  14. 14
  15. 15

    The risk of cognitive impairment in older community-dwelling women after benzodiazepine use by Lagnaoui, Rajaa, Tournier, Marie, Moride, Yola, Wolfson, Christina, Ducruet, Thierry, Bégaud, Bernard, Moore, Nicholas

    Published in Age and ageing (01-03-2009)
    “…Long-term benzodiazepine (BZD) use has been associated with cognitive impairment that was reversible [1, 21 or not [3]. Few cohort studies have examined the…”
    Get full text
    Journal Article
  16. 16

    Under‐reporting of adverse drug reactions in general practice by Moride, Y., Haramburu, F., Requejo, A. A., Bégaud, B.

    Published in British journal of clinical pharmacology (01-02-1997)
    “…Aims In post‐marketing setting, spontaneous reporting by physicians is a mode of surveillance of adverse effects associated with drug use. The objective of…”
    Get full text
    Journal Article Conference Proceeding
  17. 17

    Benzodiazepines and hip fractures in elderly people: case-control study by Pierfitte, Corinne, Macouillard, Gerard, Thicoïpe, Michel, Chaslerie, Anicet, Pehourcq, Fabienne, Aïssou, Myriam, Martinez, Béatrice, Lagnaoui, Rajaa, Fourrier, Annie, Bégaud, Bernard, Dangoumau, Jacques, Moore, Nicholas

    Published in BMJ (24-03-2001)
    “…Abstract Objective: To determine whether benzodiazepines are associated with an increased risk of hip fracture. Design: Case-control study. Participants: All…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Benzodiazepine use in an elderly community-dwelling population: Characteristics of users and factors associated with subsequent use by FOURRIER, Annie, LETENNEUR, Luc, DARTIGUES, Jean Francois, MOORE, Nicholas, BEGAUD, Bernard

    Published in European journal of clinical pharmacology (01-08-2001)
    “…The objective of this study was to describe determinants of current and subsequent benzodiazepine use in an elderly population, the Paquid cohort. The study…”
    Get full text
    Conference Proceeding Journal Article
  20. 20

    Atypical antipsychotics: From potassium channels to torsade de pointes and sudden death by TITIER, Karine, GIRODET, Pierre-Olivier, VERDOUX, Hélène, MOLIMARD, Mathieu, BEGAUD, Bernard, HAVERKAMP, Wilhelm, LADER, Malcolm, MOORE, Nicholas

    Published in Drug safety (2005)
    “…Syncope and sudden death are features of schizophrenia that can be attributed to ischaemic heart disease, the use of antipsychotics (because of proarrhythmia…”
    Get full text
    Journal Article